Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Expeditors International
EXPD
$25.2B
| $60.5M | 0.05% |
795,522
+768,224
| +2,814% | +$56.1M |
2018 Q4
6 quarters
|
|
377
Bloom Energy
BE
$80.4B
| $60.3M | 0.05% |
5,539,753
-508,100
| -8% | -$3.97M |
2019 Q3
3 quarters
|
|
378
Stride
LRN
$3.38B
| $59.9M | 0.05% |
2,198,425
+412,780
| +23% | +$9.93M |
2016 Q2
16 quarters
|
|
379
Hilton Worldwide
HLT
$72.8B
| $59.6M | 0.05% |
+810,860
| New | +$60.2M |
2020 Q2
0 quarters
|
|
380
Telephone and Data Systems
TDS
$3.93B
| $59.5M | 0.05% |
2,992,008
-167,600
| -5% | -$3.2M |
2013 Q2
28 quarters
|
|
|
SAFM
381
DELISTED
Sanderson Farms Inc
SAFM
| $59.4M | 0.05% |
512,901
-190,100
| -27% | -$24.4M |
2015 Q3
19 quarters
|
|
382
Hubbell
HUBB
$25.1B
| $59.1M | 0.05% |
471,495
+153,000
| +48% | +$18.6M |
2018 Q4
6 quarters
|
|
383
Colliers International
CIGI
$4.42B
| $59M | 0.05% |
1,029,800
+70,400
| +7% | +$3.77M |
2013 Q2
28 quarters
|
|
|
CS
384
DELISTED
Credit Suisse Group
CS
| $58.9M | 0.05% |
5,711,496
-4,220,100
| -42% | -$37.9M |
2016 Q1
17 quarters
|
|
|
ENDP
385
DELISTED
Endo International plc
ENDP
| $58.5M | 0.05% |
17,048,800
+1,382,300
| +9% | +$5.29M |
2017 Q2
12 quarters
|
|
386
Synaptics
SYNA
$4.73B
| $58.4M | 0.05% |
971,227
-285,400
| -23% | -$17.9M |
2019 Q3
3 quarters
|
|
|
XLNX
387
DELISTED
Xilinx Inc
XLNX
| $58.1M | 0.05% |
+590,505
| New | +$52.4M |
2020 Q2
0 quarters
|
|
388
Louisiana-Pacific
LPX
$4.55B
| $58M | 0.05% |
2,260,155
-418,400
| -16% | -$8.86M |
2016 Q3
15 quarters
|
|
389
Fox Class B
FOX
$24B
| $57.8M | 0.05% |
2,151,825
-403,600
| -16% | -$10.7M |
2019 Q2
4 quarters
|
|
390
Cardinal Health
CAH
$55.3B
| $57.7M | 0.05% |
1,104,894
-166,552
| -13% | -$8.59M |
2018 Q2
8 quarters
|
|
391
NextEra Energy
NEE
$161B
| $57.2M | 0.05% |
953,200
-4,226,904
| -82% | -$253M |
2020 Q1
1 quarter
|
|
392
PetMed Express
PETS
$27.7M
| $57M | 0.05% |
1,598,769
-15,400
| -1% | -$535K |
2013 Q2
28 quarters
|
|
|
NTCO
393
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $56.5M | 0.05% |
3,896,997
-525,600
| -12% | -$6.9M |
2020 Q1
1 quarter
|
|
|
HTO
394
H2O America
HTO
$2.43B
| $56.2M | 0.05% |
904,300
-190,100
| -17% | -$11.4M |
2014 Q3
23 quarters
|
|
395
Western Digital
WDC
$147B
| $56.2M | 0.05% |
1,682,767
+1,348,534
| +403% | +$43.7M |
2017 Q2
12 quarters
|
|
396
Box
BOX
$4.98B
| $56.1M | 0.05% |
2,704,212
+1,538,300
| +132% | +$27M |
2016 Q3
15 quarters
|
|
|
FIT
397
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $56.1M | 0.05% |
8,682,416
+4,267,283
| +97% | +$27.9M |
2016 Q1
17 quarters
|
|
|
CSII
398
DELISTED
Cardiovascular Systems, Inc.
CSII
| $55.9M | 0.05% |
1,771,758
+107,700
| +6% | +$4.02M |
2016 Q3
15 quarters
|
|
399
Corteva
CTVA
$9.17B
| $55.7M | 0.05% |
+2,080,500
| New | +$54.1M |
2020 Q2
0 quarters
|
|
|
MGLN
400
DELISTED
Magellan Health Services, Inc.
MGLN
| $55.7M | 0.05% |
762,719
-51,300
| -6% | -$3.28M |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.